The American Journal of Managed Care3d
Myasthenia Gravis Care Overlooks Speech and Swallowing Dysfunction
Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent ...
FDA Approves Expanded Use of Eculizumab (Soliris) for Pediatric Myasthenia Gravis, Bringing New Treatment Options for Children
The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion/AstraZeneca’s eculizumab (Soliris) for pediatric patients ...
MedPage Today6d
Myasthenia Gravis Exacerbations
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular ...
MedPage Today on MSN5d
Myasthenia Gravis Exacerbations
Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction ...
pharmaphorum2d
UCB bags FDA approval for second myasthenia gravis drug
Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...
Indiatimes2d
Graviss Hospitality Share Price
Graviss Hospitality Ltd., incorporated in the year 1959, is a Small Cap company (having a market cap of Rs 310.28 Crore) operating in Tourism & Hospitality sector. Graviss Hospitality Ltd. key ...